Linda Burkly Editas Medicine, Inc. (EDIT) insider trading activity

Linda Burkly is EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine, Inc.. Currently has a direct ownership of 68,777 shares of EDIT, which is worth approximately $178,820. The most recent transaction as insider was on Dec 03, 2025, when has been sold 713 shares (Common Stock) at a price of $2.15 per share, resulting in proceeds of $1,532. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.8K

1.03% 3M change

5.96% 12M change

Total Value Held $178,820

Linda Burkly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 03 2025	SELL Open market or private sale	$1,532 $2.15 p/Share	713 Reduced 1.03%	68,777 Common Stock
Sep 03 2025	SELL Open market or private sale	$1,846 $2.6 p/Share	710 Reduced 1.01%	69,490 Common Stock
Jul 31 2025	SELL Open market or private sale	$12,751 $2.49 p/Share	5,121 Reduced 7.37%	64,398 Common Stock
Jun 03 2025	SELL Open market or private sale	$1,248 $1.72 p/Share	726 Reduced 1.03%	69,519 Common Stock
Mar 04 2025	SELL Open market or private sale	$4,943 $1.71 p/Share	2,891 Reduced 3.95%	70,245 Common Stock
Jul 25 2024	SELL Open market or private sale	$64,422 $5.42 p/Share	11,886 Reduced 13.98%	73,136 Common Stock
Mar 02 2024	BUY Grant, award, or other acquisition	-	39,855 Added 31.92%	85,022 Common Stock

Jul 24 2023	BUY Grant, award, or other acquisition	-	45,167 Added 50.0%	45,167 Common Stock

Linda Burkly

EVP, CHIEF SCIENTIFIC OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDIT shares.

Notify only if

Value

Insider Trading

Get notified when an Editas Medicine, Inc. insider buys or sells EDIT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Editas Medicine, Inc.

Track Activities on EDIT

Account